Sort
17,828 grants matching “crispr”
Mechanisms of Myotonic Dystrophy Type 2-causing CCTG DNA Repeat Instability
$111,750Jane C Kim · California State University San Marcos · SC3 · FY2021 · GM
Mechanisms of Myotonic Dystrophy Type 2-causing CCTG DNA Repeat Instability
$111,750Jane C Kim · California State University San Marcos · SC3 · FY2019 · GM
Identifying Metabolic Vulnerabilities in Pancreatic Cancer
$111,585Douglas Biancur · New York University School Of Medicine · K00 · FY2024 · CA
Developing CRISPR repeats as a means of phylogenetically profiling metagenomic data
$111,581Philip Lee Falk Johnson · Univ Of Maryland, College Park · R21 · FY2023 · GM
Dissection of genetic and circuit mechanisms underlying fear memory generalization.
$111,543Priya Rajasethupathy · Stanford University · K99 · FY2016 · MH
Mechanistic Basis for ERK in driving KRAS-dependent pancreatic cancer
$111,438Jennifer E Klomp · Univ Of North Carolina Chapel Hill · K99 · FY2024 · CA
Mechanistic Basis for ERK in driving KRAS-dependent pancreatic cancer
$111,438Jennifer E Klomp · Univ Of North Carolina Chapel Hill · K99 · FY2023 · CA
Epigenetic regulation of PDE signaling in dilated cardiomyopathy
$111,415Haodi Wu · Stanford University · K99 · FY2017 · HL
Establishing combinatorial screening platform coupled to single-cell analysis
$111,335Michael Aregger · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Developing CRISPR repeats as a means of phylogenetically profiling metagenomic data
$111,291Philip Lee Falk Johnson · Univ Of Maryland, College Park · R21 · FY2022 · GM
Transgenic & Gene-Targeting Shared Resource
$111,113Jay L Vivian · University Of Kansas Medical Center · P30 · FY2022 · CA
Control of ribosomal function in cells of the hematopoietic system
$111,089Andrew Levine · University Of California, San Francisco · K38 · FY2023 · HL
Control of ribosomal function in cells of the hematopoietic system
$111,089Andrew Levine · University Of California, San Francisco · K38 · FY2022 · HL
Reprogramming and Directed Differentiation of Skeletal Muscle Cells from hPSCs
$110,997April D Pyle · University Of California Los Angeles · R01 · FY2021 · AR
Democratizing CAR T cell therapy by in situ programming of virus-specific T cells
$110,905Fang-Yi Su · Georgia Institute Of Technology · K99 · FY2023 · CA
Democratizing CAR T cell therapy by in situ programming of virus-specific T cells
$110,905Fang-Yi Su · Georgia Institute Of Technology · K99 · FY2024 · CA
Targeted disruption of the YAP/TAZ/TEAD axis in pancreatic cancer
$110,651Behnam Nabet · Fred Hutchinson Cancer Research Center · K22 · FY2021 · CA
The role of small RNA modifications in glioma
$110,646Zhangli Su · University Of Alabama At Birmingham · K99 · FY2023 · CA
The role of small RNA modifications in glioma
$110,646Zhangli Su · University Of Alabama At Birmingham · K99 · FY2022 · CA
Investigating roles for oxidative guanine damage in transcription regulation
$110,568Mariarosaria De Rosa · University Of Pittsburgh At Pittsburgh · K99 · FY2024 · ES
Investigating roles for oxidative guanine damage in transcription regulation
$110,568Mariarosaria De Rosa · University Of Pittsburgh At Pittsburgh · K99 · FY2025 · ES
Investigating the Alternative Splicing Landscape of Human Retinal Development and Degeneration
$110,407Casey Keuthan · Johns Hopkins University · K99 · FY2024 · EY
Investigating the Alternative Splicing Landscape of Human Retinal Development and Degeneration
$110,407Casey Keuthan · Johns Hopkins University · K99 · FY2025 · EY
Identification of Molecular Mechanisms Underlying Early Atherosclerosis
$110,403Genesio Karere · Wake Forest University Health Sciences · K01 · FY2020 · HL
Delineating mechanisms underlying azole-induced developmental toxicity using single cell transcriptomic approaches, genome editing tools, and alternative models
$110,342Joshua Frederick Robinson · University Of California, San Francisco · R01 · FY2024 · ES